XLY.V - Auxly Cannabis Group Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.9000
+0.0100 (+1.12%)
As of 12:51PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.8900
Open0.9000
Bid0.89 x 0
Ask0.90 x 0
Day's Range0.8900 - 0.9100
52 Week Range0.6000 - 1.6200
Volume522,726
Avg. Volume1,931,920
Market Cap528.027M
Beta (3Y Monthly)15.61
PE Ratio (TTM)N/A
EPS (TTM)-0.10
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.68
  • GlobeNewswire13 days ago

    REPEAT - New Danish Cannabis Export Regulations Very Positive for ICC; Auxly Uruguay Distribution Partnership Moves Toward Commercialization

    VANCOUVER, British Columbia, Jan. 10, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U) (FWB: 8K51) (OTC: KNHBF) ("ICC" or “International Cannabis” or the “Company”) is.

  • GlobeNewswire14 days ago

    Auxly Announces Completion of Inverell S.A. Acquisition

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (the "Company") is pleased to announce that, further to its previous releases, it has completed the acquisition of 80% of the outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company's strategic partnership with ICC International Cannabis Corporation Inc. (CSE:WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies.

  • Inner Spirit Holdings Provides December 2018 Sales Results, Year-End Highlights and 2019 Strategy Update
    CNW Group15 days ago

    Inner Spirit Holdings Provides December 2018 Sales Results, Year-End Highlights and 2019 Strategy Update

    CALGARY, Jan. 8, 2019 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company") (CSE:ISH.CN - News) today provided its December 2018 sales results, recapped its year-end highlights, and delivered a strategy update for 2019. Inner Spirit reported system-wide retail sales of $2,253,919 for the month of December.

  • GlobeNewswire26 days ago

    Auxly Strengthens Board of Directors Through the Appointment of Genevieve Young and Jean-Paul Gaillard as Independent Directors

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce the appointment of Genevieve Young and Jean-Paul Gaillard as independent members of its board of directors, effective immediately. Following the appointments, Auxly’s board will consist of five members, three of whom are independent from the Company. Genevieve Young is the President and Chief Operating Officer of Global Public Affairs, Canada’s leading privately held strategic communications and government advocacy consultancy representing some of Canada’s largest and most dynamic organizations.

  • Baystreetlast month

    5 Stocks To Watch As Cannabis Goes Global

    Did you miss out on the last cannabis boom? Don't worry. Another one may be right around ...

  • How A NASA Scientist Could Trigger The Next Cannabis Boom
    Oilprice.comlast month

    How A NASA Scientist Could Trigger The Next Cannabis Boom

    The easy money is gone in cannabis, but growers and investors are now betting big on new technologies that can significantly boost profits in this booming sector

  • GlobeNewswire2 months ago

    Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Cannabis Genetics Company Green Gene Research Inc

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its strategic international partner, ICC International Cannabis Corp. ("ICC") (CSE:WRLD), has entered into a definitive agreement to acquire all of the issued and outstanding shares of Green Gene Research Inc. (“Green Gene”), a cannabis genetics company with significant experience in cannabis research, testing, cultivation and the optimization of proprietary seeds and strains. In addition, Green Gene controls a portfolio of over 120 laboratory-tested unique cannabis strains carefully curated over the past 17 years of Green Gene’s operations. In connection with the strategic investment and commercial rights agreement announced on September 17, 2018, Auxly has become a preferred commercial partner to ICC on its current and future international and domestic cannabis ventures, including Green Gene, for a period of 10 years.

  • GlobeNewswire2 months ago

    Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Portuguese Hemp Company

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its strategic international partner, ICC International Cannabis Corp. ("ICC") (CSE:WRLD), has entered into a definitive agreement to acquire all issued and outstanding shares of Enigma Unipessoal Lda (“Enigma”). Enigma is a large-scale hemp operator based in Castelo Branco, Portugal with licenses to cultivate, extract, import, export and process hemp derived products on 400 acres of land. Having acquired one of the first hemp licenses to be issued in Portugal, Enigma successfully harvested its first crop in 2015 and is a notable importer of proprietary hemp seeds.

  • GlobeNewswire2 months ago

    Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") has reported its financial and operational results for the three and nine months ended September 30th, 2018. Auxly’s management team has prioritized the following objectives for each of the Company’s business segments. Upstream: The Company continues to acquire cultivation capacity through the development of facilities in Canada and Uruguay.

  • GlobeNewswire3 months ago

    Auxly Announces Receipt of SENACLAFT Approval and Closing of Inverell S.A. Acquisition

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to the binding interim agreement announced on January 30th, 2018, the Company has received approval from the Secretaría Nacional para la Lucha contra el Lavado de Activos y el Financiamiento del Terrorismo (“SENACLAFT”), the government body overseeing foreign direct investments in Uruguay, for the Company’s acquisition of 80% of the issued and outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). Inverell is a federally licensed Cannabis Operator based in Montevideo, Uruguay. Led by Dr. Raúl Urbina, Inverell is a large-scale outdoor producer of hemp plants for CBD extraction operating on an initial footprint of approximately 300 hectares.

  • Baystreet3 months ago

    Buy the Hype: Smart Cannabis Companies Aggressively Expanding Overseas

    Those that scoffed at upstart companies centering their business on the cannabis industry, mocking ...

  • CNW Group4 months ago

    High Tide Congratulates FSD Pharma for Achieving $1 Billion Market Capitalization and Its Other Recent Successes

    CALGARY, Sept. 21, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it congratulates FSD Pharma Inc. (CSE:HUGE) ("FSD Pharma") for achieving a $1 Billion market capitalization and its other recent successes. The Company would like to commend FSD Pharma on reaching such a significant valuation milestone in the Canadian cannabis market, which only a small number of other companies have been able to achieve.  Further, High Tide would also like to acknowledge the significance of FSD Pharma's recent receipt of $7.5 Million from Auxly Cannabis Group Inc. (TSX.V:XLY.V - News) ("Auxly"), at a premium to its recent market share price, to further fund construction of its 220,000 square foot cultivation facility in Cobourg, Ontario.

  • FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.
    CNW Group4 months ago

    FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.

    TORONTO, Sept. 20, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (CSE:HUGE.CN - News) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSX.V – XLY) ("Auxly") has made an equity investment into the Company at $1.00 per Class B Subordinate Voting Share for total proceeds of $7.5 million. The buildout of the Joint Cultivation Footprint is currently underway in Cobourg, Ontario and will include dedicated space for large scale extraction capabilities. In addition to the Joint Cultivation Footprint, FSD is also implementing several technological advancements at the Cobourg facility aimed at increasing energy efficiency and post-harvest process automation.

  • ACCESSWIRE4 months ago

    3 Canadian Marijuana Stocks Continuing to Trade Higher in September

    CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Canadian marijuana stocks continue to lead the sector as the October deadline looms. In roughly 1 month Canada will begin legal sale of recreational marijuana across the country but this is just the beginning for the country. The move by Canada effectively makes the country the first G7 nation to legalize recreational cannabis use and further opens opportunities for companies in Canada to export marijuana as well.

  • Baystreet5 months ago

    Stocks in play: Auxly Cannabis Group Inc.

    Has completed its previously announced acquisition of all of the outstanding shares of KGK Science Inc. ...